Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of DA-5223 vs DA-5223-R in Healthy Adults
NCT07007533Phase 1Completed
- Sponsor
- Dong-A ST
- Start
- Jul 2025
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of limaprost in lumbar spinal stenosis (LSS) (2 arms), sponsored by Dong-A ST. Primary endpoints: Area Under the Curve from time 0 to 24 hours and Maximum Plasma Concentration. Started Jul 2025; status: completed.
02
Drugs
limaprost
03
Conditions
lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on NCT07007533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07007533.